{"name":"Lynn Malec","slug":"lynn-malec","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"rtPA lock therapy","genericName":"rtPA lock therapy","slug":"rtpa-lock-therapy","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"rtPA lock therapy","genericName":"rtPA lock therapy","slug":"rtpa-lock-therapy","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTFB5T1RjSTNmSjd6Nnp3bE9EaUY4QmNNZ29EVzB0bjN3eDUwWHVpQkRBSXctLW5vcGpuSG1NV1NNcjBXQV9mNWlhYkdlMl96Mm5IR1VEcEZJSWgtbmpTRXdFM2dHWjQteXFMNEh0RklVTlUtTWp4VERTRnptV1B2QQ?oc=5","date":"2026-02-19","type":"pipeline","source":"Legacy","summary":"Lynn Marie Malec Obituary (2026) - Hartford, WI - Shimon Funeral Home - Legacy","headline":"Lynn Marie Malec Obituary (2026) - Hartford, WI - Shimon Funeral Home","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiaEFVX3lxTE9zS2xfMEdmb2o4NDNqZmlIc0VSLS1xbmhhczVPcWtUVWxqalFLZWF1RS0wN2NKWlNWUWFhWVMtMVdsVzlJWkQtRGtWaUNDbFUxZjJHM1JhMzRtbm5CN2xJTFhVcW01c1Fp?oc=5","date":"2025-03-18","type":"trial","source":"Wiley Online Library","summary":"Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids Studies - Wiley Online Library","headline":"Perioperative Management With Efanesoctocog Alfa in Patients With Haemophilia A in the Phase 3 XTEND-1 and XTEND-Kids St","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB2RVc2UFJNNEZXaFBrZWpZeU9wd3dWM0hKWFkyWjJCOGtzRjhXTTlnWmc3STkzdUUwMjFiXzVRcUc3VWNEanVhVU9yMmh1ZFlVcEx6dVpqSGJXRUt4N2Zv?oc=5","date":"2024-07-17","type":"pipeline","source":"NEJM","summary":"Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A - NEJM","headline":"Efanesoctocog Alfa Prophylaxis for Children with Severe Hemophilia A","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}